Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 · JAMA Oncology · 3,401 citations
https://doi.org/10.1001/jamaoncol.2017.0589
J
James C. Yao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
587
Papers
38.6K
Citations
80
h-index
230
i10-index
James C. Yao is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Lung Cancer Research Studies & Neuroblastoma Research and Treatments. The author has an h-index of 80, co-authored 499 publications.
ORCID: 0000-0002-1875-3962Papers by this author
worksPhase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
2017 · New England Journal of Medicine · 3,053 citations
https://doi.org/10.1056/nejmoa1607427
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 · New England Journal of Medicine · 2,831 citations
https://doi.org/10.1056/nejmoa1009290
Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set
2010 · The American Journal of Surgical Pathology · 354 citations
https://doi.org/10.1097/pas.0b013e3181ce1447
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
2023 · The Lancet · 279 citations
https://doi.org/10.1016/s0140-6736(23)00772-9
Thymic Neuroendocrine Tumors
2010 · Annals of Surgery · 172 citations
https://doi.org/10.1097/sla.0b013e3181dd4ec4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat